Compare Motorola Solutions Inc (MSI) vs Organon & Co. Common Stock (OGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Motorola Solutions Inc vs Organon & Co. Common Stock — how do they compare? Motorola Solutions Inc trades at $455.97 (market cap $74.76B), while Organon & Co. Common Stock trades at $13.73 (market cap $3.61B). The key difference: Motorola Solutions Inc is far larger — about 20.7× Organon & Co. Common Stock's market cap, and Motorola Solutions Inc pays the higher dividend (1.07%). Which is the better fit depends on your goals — on Pluang, investors hold Motorola Solutions Inc for 101 Days and Organon & Co. Common Stock for 0 Days on average.
| MSI | OGN | |
|---|---|---|
Market Cap | $74.76B | $3.61B |
Volume | 541,174 | 1,808,049 |
Sector | Technology | Health |
52-Week High | $491.24 | $13.81 |
52-Week Low | $363.83 | $5.70 |
Typical Hold Time | 101 Days | 0 Days |
Enterprise Value | $83.67B | $11.03B |
Dividend Yield | 1.07% | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Motorola Solutions (MSI) trades at $449.01, up 0.64% today, with a neutral technical signal. The company shows strong fundamentals: revenue grew to $11.68B in 2025, net income margin is 17.44%, and it has beaten EPS estimates for three consecutive quarters. Recent news includes a $1.5B acquisition of D-Fend Solutions and a $139M public safety contract in Louisiana, highlighting growth in defense and security segments. Cash flow from operations is robust at $2.84B, though net cash flow was negative due to significant investing activities.
Outlook is positive given analyst consensus of a $525.86 price target and 70.59% buy ratings, supported by record backlog and strategic acquisitions. Risks include high valuation multiples (P/E 35.38) and increased debt levels, with net cash flow turning negative in 2025-2026. The stock offers growth potential in mission-critical solutions but faces execution risks from integration of recent buys and competitive pressures.
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →
